Clinical Trials Sponsored by Luminary Therapeutics
Total 6362 results
-
Entasis TherapeuticsCompletedAcute Pyelonephritis | Complicated Urinary Tract InfectionBulgaria
-
MC2 TherapeuticsCompleted
-
Atacama TherapeuticsCompletedPalmar HyperhidrosisUnited States
-
Centrexion TherapeuticsCompletedPain | Chronic Pain | Nociceptive PainUnited States
-
MC2 TherapeuticsCompleted
-
PTC TherapeuticsWithdrawn
-
Heron TherapeuticsCompleted
-
Cytori TherapeuticsSuspendedThermal BurnUnited States
-
Celldex TherapeuticsTerminated
-
Entasis TherapeuticsCompletedAcinetobacter Baumannii-calcoaceticus Complex InfectionsUnited States
-
Aptevo TherapeuticsCompletedProstate CancerUnited States, Australia
-
Acorda TherapeuticsCompletedIdiopathic Parkinson's DiseaseUnited States, Canada, Czechia, Poland, Spain
-
Proteon TherapeuticsCompletedChronic Kidney DiseaseUnited States, Canada
-
Corcept TherapeuticsTerminatedCushing Syndrome | HypercortisolismUnited States
-
Effector TherapeuticsTerminatedHepatocellular Carcinoma | Triple Negative Breast CancerUnited States
-
Cyclerion TherapeuticsCompleted
-
BioMimetic TherapeuticsCompletedLateral EpicondylitisUnited States
-
Cyclerion TherapeuticsCompletedHealthy VolunteersUnited States
-
Acorda TherapeuticsCompletedIdiopathic Parkinson's DiseaseUnited States, Austria, Belgium, Czechia, France, Germany, Hungary, Israel, Netherlands, Poland, Romania, Serbia, Spain, United Kingdom
-
Acorda TherapeuticsCompletedIdiopathic Parkinson's DiseaseUnited States, Canada, Czechia, Poland, Spain
-
Therapeutics, Inc.CompletedAcne VulgarisUnited States
-
Elusys TherapeuticsCompletedInhalational AnthraxUnited States
-
Proteon TherapeuticsCompletedPeripheral Artery DiseaseUnited States
-
Elusys TherapeuticsCompletedInhalational AnthraxUnited States
-
Cyclerion TherapeuticsCompletedHealthyUnited States
-
Cyclerion TherapeuticsCompletedHealthyUnited States
-
Akebia TherapeuticsCompleted
-
Akebia TherapeuticsCompletedDrug Interaction PotentiationCanada
-
Intarcia TherapeuticsTerminatedType 2 DiabetesUnited States
-
Amicus TherapeuticsTerminatedLate-onset Pompe DiseaseUnited States, Canada, Australia, Belgium
-
Halozyme TherapeuticsTerminated
-
Halozyme TherapeuticsCompleted
-
Abide TherapeuticsCompletedMultiple Sclerosis | Neuromyelitis Optica Spectrum Disorder | Transverse Myelitis | Longitudinally Extensive Transverse MyelitisUnited Kingdom
-
Corcept TherapeuticsCompletedCushing's SyndromeUnited States
-
Acorda TherapeuticsTerminatedPost-ischemic StrokeUnited States, Canada
-
Balance TherapeuticsCompletedIdiopathic Hypersomnia | Narcolepsy Without CataplexyUnited States
-
Halozyme TherapeuticsCompletedStage IV Pancreatic CancerUnited States, Russian Federation
-
Therapeutics, Inc.CompletedPlaque PsoriasisUnited States
-
Amicus TherapeuticsCompletedFabry DiseaseFrance, Austria, United States, Belgium, Japan, United Kingdom, Denmark, Brazil, Australia, Italy
-
Amicus TherapeuticsCompletedFabry DiseaseUnited States, Italy, Spain, Turkey, Brazil, Canada, United Kingdom, France, Poland, Australia, Egypt, Argentina, Denmark
-
Therapeutics, Inc.CompletedPsoriasis | Plaque PsoriasisUnited States
-
Cognition TherapeuticsCompleted
-
Amicus TherapeuticsCompletedFabry DiseaseUnited States, Australia, France, United Kingdom, Brazil, Canada
-
Amicus TherapeuticsTerminatedFabry DiseaseAustralia, United States, Italy, Spain, Belgium, Turkey, Brazil, Argentina, United Kingdom, Denmark, France, Canada, Egypt
-
Amicus TherapeuticsCompleted
-
Amicus TherapeuticsCompletedGaucher Disease | Gaucher Disease, Type 1 | Type 1 Gaucher DiseaseUnited States
-
Halozyme TherapeuticsCompletedRisk Factors for or a Diagnosis of OsteoporosisUnited States
-
Amicus TherapeuticsCompletedGaucher Disease | Gaucher Disease, Type 1 | Type 1 Gaucher DiseaseUnited Kingdom, Israel, South Africa, United States
-
Acorda TherapeuticsCompletedIdiopathic Parkinson's DiseaseUnited States, Italy, Serbia, United Kingdom